Safety Alert for Trade name: Aesculap single use bipolar instrument. Technical name: Aesculap single use bipolar instrument. ANVISA registration number: 80136990832. Risk class: III. Model affected: Caiman 5 mm. Affected Batches / Series Numbers: See Attachment "List of Batches Under Risk"

According to Agência Nacional de Vigilância Sanitária (ANVISA), this safety alert involved a device in Brazil that was produced by Laboratórios B. Braun S.A.; Aesculap AG.

What is this?

Alerts provide important information and recommendations about products. Even though an alert has been issued, it does not necessarily mean a product is considered to be unsafe. Safety Alerts, addressed to health workers and users, may include recalls. They can be written by manufacturers, but also by health officials.

Learn more about the data here
  • Type of Event
    Safety alert
  • Event ID
    2566
  • Date
    2018-05-07
  • Event Country
  • Event Source
    ANVISA
  • Event Source URL
  • Notes / Alerts
    Brazilian data is current through June 2018. All of the data comes from Anvisa, except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of data from the U.S. and Brazil.
  • Extra notes in the data
    Interruption of the use of said lot numbers, segregation thereof and information to Laboratorios B. Braun SA, for collection. The manufacturer informs that it has updated the instructions for use for the products. If you wish to notify technical complaints and adverse events use the following channels: Notivisa: Notices of adverse events (AE) and technical complaints (QT) for products subject to Sanitary Surveillance should be made through the NOTIVISA System. To access the System, you must register and select the Health Professional option, if you are a liberal professional or the Institution / Entity option, if you are a professional of an institution / entity. Technovigilance System: Patient or citizen can notify through the Technovigilance System / SISTEC access through the link Additional information: - Date of identification of the problem by the company: 12/04/2018 - Date of notification notice to Anvisa: 04/20/2018 The company that owns the affected product is responsible for contacting its customers in due time. to ensure the effectiveness of the Field Action in progress. It stands out the joint responsibility of the distribution chain and use of health products in maintaining its quality, safety and efficacy, as well as the effectiveness of the Field Action, expressed by RDC 23/2012: "(...) Art 2 ° A holder of registration of health product is the holder of the registration / registration of health product with Anvisa. Single paragraph. The registration holder, as well as other agents involved from the production to the use of the product, or discarding it when applicable, are jointly and severally responsible for maintaining the quality, safety and efficacy of the health products to the final consumer. Art. 12 Distributors of health products shall forward to the registration holder, in a timely manner, the distribution map and other information requested for the notification and execution of field actions. (...) "
  • Reason
    Aesculap ag has identified the possibility of arcing (carbonization) at the tip of the caiman 5 product, which can lead to failures during use. the registry holder informs that the problem is related to the following causes:> inadequate cleaning during surgery, so that blood and tissue wastes begin to carbonize; > damage to the dissecting clip insulation, which may be caused by improper handling while cleaning the electrodes.
  • Action
    Field Action Code AC / 02/2018 triggered under the responsibility of the company Laboratorios B. Braun SA Recolhimento.

Manufacturer